SCHEMBL23022802

SCHEMBL23022802

Cc1ccc(C(=O)Nc2ccccc2CNC(C)CC2CCCCC2)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
F2RL1 P55085 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
LDLR P01130 1/20 0.35
PDCD1 Q15116 2/20 0.35
CD274 Q9NZQ7 2/20 0.35
P2RX7 Q99572 1/20 0.35
NPY5R Q15761 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
DRD1 P21728 1/20 0.34
HRH2 P25021 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192548 0.84 KMT2A (0.47) KMT2AALDH1A1F2RL1KDM4EP2RX7
SCHEMBL4197332 0.84 CTSL (0.44) KMT2AALDH1A1F2RL1KDM4ECTSL
SCHEMBL4190624 0.84 CTSL (0.44) KMT2AALDH1A1F2RL1KDM4ECTSL
SCHEMBL4198225 0.84 CTSL (0.44) KMT2AALDH1A1F2RL1KDM4ECTSL
SCHEMBL4192323 0.82 KMT2A (0.44) KMT2AALDH1A1LMNAF2RL1KDM4E
SCHEMBL4186006 0.82 KMT2A (0.44) KMT2AALDH1A1LMNAF2RL1KDM4E
SCHEMBL4184490 0.82 MEN1 (0.47) KMT2AALDH1A1LMNAKDM4ECTSL
SCHEMBL4193519 0.82 MEN1 (0.47) KMT2AALDH1A1LMNAKDM4ECTSL
SCHEMBL4189868 0.82 LDLR (0.46) KMT2ALMNAF2RL1KDM4ECTSL
SCHEMBL23022938 0.81 EPHX1 (0.36) F2RL1KDM4ENPY5RTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210053997-A1 TRNA SYNTHETASE INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2021-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053997-A1 TRNA SYNTHETASE INHIBITORS TRMT1, AARS1, GARS1 KMT2A 1187/4885ALDH1A1 2254/4885LMNA 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.